Cook, Patheon approved to make Halozyme drug; Italy's Gyma recalls APIs over GMP issues;

> Halozyme Therapeutics ($HALO) says the FDA has approved the Cook Pharmica manufacturing facility in Bloomington, IN, for production of the API in its Hylenex recombinant (hyaluronidase human injection) and a Patheon facility in Greenville, NC, for production of finished Hylenex product. Report

> Italy's Gyma is recalling a number of APIs after a Rapid Alert Notification was issued by the Italian Medicines Agency due to lack of good manufacturing practices. Notice

> Even after FDA recalls, supplements containing unapproved ingredients remain on the market. Story